semaglutide for weight loss oral FDA Approves as the First Oral GLP-1 Pill 50 mg of oral #semaglutide

At the time of writing (October 2024), the primary recommendation comes from ANZCAs Clinical Practice Recommendation On Periprocedural Use Of GLP-1/GIP Receptor Agonists

Lipolysis: Breakdown of fats to release fatty acids, affected by weight loss treatments

Additionally, it helps regulate blood sugar, reduce cravings, and support cardiovascular health, making it ideal for individuals with both weight and metabolic concerns

Diabetologia 47, 357366

GLP-1 and its analogues are known to exert multifaceted beneficial effects on GI physiology, including enhancement of mucosal barrier integrity, modulation of intestinal motility, and regulation of immune responses within the gut mucosa